PRT-064040 nasal spray for migraine in adults
Part of Brain & nervous system clinical trials.
This trial tests a new nasal spray, PRT-064040, to see if it can help treat migraine attacks. It is for adults who have had migraines for at least a year and get 2 to 8 moderate to severe migraines per month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had migraines for at least 1 year, starting before age 50.
- You get 2 to 8 moderate to severe migraine attacks each month.
- You have fewer than 15 headache days per month (including non-migraine headaches).
- Your body mass index (BMI) is under 35.
- You do not have certain heart or blood vessel conditions, or nasal problems that could affect the spray.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
This study tests a new medication called NB001 to help stop migraine headaches when they happen. Researchers want to see if it works better than current treatments for people who have frequent migraines.
This trial tests if oral NBP soft capsules can prevent migraine attacks in adults. It compares the drug against a placebo to see if it reduces how often migraines occur.
This trial tests a new medicine, MEDI0618, against a placebo for people with episodic migraine. The goal is to see if MEDI0618 is safe and effective at reducing migraine days.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.